Exploring Biologics: A New Frontier in Managing Pediatric Severe Asthma

In the evolving field of pediatric pulmonology, severe asthma represents a significant challenge due to its complexity and the substantial impact on young patients' quality of life. Traditional therapeutic approaches often fall short in managing severe cases in children, indicating a necessity for alternative treatments. Recent advancements have brought biologic therapies to the forefront, offering targeted interventions based on specific inflammatory pathways and immunological profiles. However, despite these innovations, comprehensive knowledge about the efficacy and safety of biologics in children remains limited, creating a compelling need for focused research to bridge this gap.This Research Topic aims to expand the current understanding of the effectiveness and safety of biologic treatments for severe asthma in the pediatric population. By exploring a variety of biologic agents, the goal is to delineate their roles and outcomes in clinical pediatric practice, assessing both short-term efficacy and long-term health impacts.To advance the knowledge in pediatric severe asthma management, this research focuses primarily on clinical applications and outcomes of biologic therapies. We welcome articles addressing, but not limited to, the following themes:· Comparative studies of biologic treatments versus traditional therapies· Long-term safety profiles of biologics in children· The impact of biologic treatments on pediatric patients' quality of life· Mechanisms of action of biologics in the context of pediatric asthma· Clinical guidelines and protocols for the implementation of biologic therapies in pediatric settings Topic editors: Sara Manti, Amelia Licari Source: https://www.frontiersin.org/research-topics/68787/exploring-biologics-a-new-frontier-in-managing-pediatric-severe-asthma